# Fentanyl vs. Remifentanil in Laparoscopic Cholecystectomy: Effects on Bowel Function and Pain

> **NCT07182097** · NA · RECRUITING · sponsor: **Konya City Hospital** · enrollment: 106 (estimated)

## Conditions studied

- Postoperative Bowel Function
- Postoperative Pain

## Interventions

- **DRUG:** Fentanyl 2 µg/kg IV bolus + 1-2 µg/kg/h infusion during anesthesia
- **DRUG:** Remifentanil 1 µg/kg IV bolus + 0.1-1 µg/kg/min infusion during anesthesia

## Key facts

- **NCT ID:** NCT07182097
- **Lead sponsor:** Konya City Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-19
- **Primary completion:** 2026-04-27
- **Final completion:** 2026-04-30
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182097, "Fentanyl vs. Remifentanil in Laparoscopic Cholecystectomy: Effects on Bowel Function and Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07182097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*